Gievers-zuniga Foot & Ankle Center Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 18111 Prince Philip Dr Ste 328, Olney, MD 20832 Phone: 301-570-3668 Fax: 301-570-4770 |
Mr. Marc Evan Goldberg, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 3408 Olandwood Ct, Suite 204, Olney, MD 20832 Phone: 301-924-5044 Fax: 301-924-5933 |
Family Foot & Ankle Associates Of Maryland, P.a. Podiatrist - Primary Podiatric Medicine Medicare: Medicare Enrolled Practice Location: 3408 Olandwood Ct, Suite 204, Olney, MD 20832 Phone: 301-924-5044 Fax: 301-924-5933 |
Mrs. Donna Ann Gievers-zuniga, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 18111 Prince Philip Dr, 328, Olney, MD 20832 Phone: 301-570-3668 Fax: 301-570-4770 |
Dr. Neil R. Ohora, DPM Podiatrist - Foot Surgery Medicare: Accepting Medicare Assignments Practice Location: 18111 Prince Phillip Dr, S-212, Olney, MD 20832 Phone: 301-774-1200 Fax: 301-774-5820 |
Dr. Christopher Paul Farnworth, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 3408 Olandwood Ct, Suite 204, Olney, MD 20832 Phone: 301-924-5044 Fax: 901-924-5933 |
News Archive
The Columbus Dispatch reports that a health-insurance co-operative founded by Tom Rose, a retired businessman from Marietta, Ohio, "hopes to give people who feel alone in the health-care market that power-in-numbers feeling. ... Benefits Unlimited Inc. started in 2007 and started accepting dues-paying members across the nation last month. ... Annual dues range from $25 for an individual or household to $1,500 for employers or associations with 500 or more people.
Advanced Instruments, Inc., a leader in laboratory instrumentation, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its GloCyte Automated Cell Counter System and GloCyte Low and High Level Controls.
An international team of researchers has developed a non-invasive blood test that can detect whether an individual has one of five common types of cancers, four years before the condition can be diagnosed with current methods. The test detects stomach, esophageal, colorectal, lung and liver cancer.
Today, the American Gastroenterological Association announced that Takeda Pharmaceuticals U.S.A., Inc. will provide a $1.5 million unrestricted grant to the AGA Research Foundation endowment.
› Verified 1 days ago